TRANSLAD - Translational medicine in development disorders
  • LabKey Access
  • French
  • English

TRANSLAD - Translational medicine in development disorders

TRANSLAD

A best-practice project focussing specifically on the development of healthcare, research and education in the area of rare developmental disorder diseases.

The principal axes of FHU-TRANSLAD
  • Treat Treat

    A centre for patient evaluation and multidisciplinary care

  • Innovate Innovate

    A diagnostic centre at the cutting edge of molecular genetic technology.

  • Teach and Train Teach and Train

    A training and genomics information referral centre for hereditary diseases

  • Humanise Humanise

    A think-tank on societal and ethical issues

  • Find Find

    A clinical, molecular, neuro-cognitive and pathophysiological research centre

  • Home
  • Introduction
  • Diseases involved
  • Principal Axes
    • Area 1 : Treat
    • Area 2 : Innovate
    • Area 3 : Teach and Train
    • Area 4 : Humanise
    • Area 5 : Find
  • Follow-up
  • Coordination
  • Teams
    • Presentation
    • Diagnostics and healthcare teams included in FHU
    • Research teams included in FHU
    • Teams partnering with FHU-TRANSLAD
  • Support us
  • Home
  • Home
  • Principal Axes
  • Innovate
  • The Dijon Bourgogne University Hospital high-throughput sequencing platform

The Dijon Bourgogne University Hospital high-throughput sequencing platform

The Dijon Bourgogne University Hospital high-throughput sequencing platform is equipped with two sequencers: a MiSeq (Illumina), funded by the rare diseases national plan 2 (PNMR2) and a NextSeq 500 (Illumina). The molecular biology laboratory equipment also includes a BioAnalyzer 2100 (Agilent), a Qubit fluorometer (Life Technologies), a sonicator (Bioruptor) and standard and qualitative PCR machines, as well as the necessary devices for preparing samples for high-throughput sequencing.

What kind of diagnostics ?

This is the only platform in France that performs high-throughput target sequencing on a number of genes responsible for syndromes entailing dermatological disorders and mosaic-activating genomic mutations (AKT1, PIK3CA, etc.). In the case of high-throughput exome sequencing, the raw sequencing data is not produced on the platform but is outsourced to a private service provider.

A data management server

The Labkey server is a secure data management web platform via which the challenge of monitoring operations in the molecular genetics laboratory can be addressed. It provides a stable, adaptable database that links patient clinical data, tracks samples for molecular genetics, and can also be used for following through on tests and tracking test results. The server also has data analysis and data sharing capabilities for enhancing comprehensive patient follow-up.

Area 2 : Innovate

  • Introduction
  • The Dijon Bourgogne University Hospital high-throughput sequencing platform
    • High-throughput sequencing
  • The bioinformatics platform for data analysis
  • The Dijon Bourgogne University Hospital Functional Unit for innovation in rare disease diagnostics
    • Intellectual Disability and Developmental Disorders
    • Mosaic-activating developmental disorders with cutaneous expression
  • The Orphanomix Spin-Off

Find out more

  • Illumina
  • Data centre, UB
  • Labkey Server

 

Platform manager: Prof. Christophe Philippe
Bioinformatics engineer: Yannis Duffourd
Technical managers: Martin Chevarin, Thibaut Jouan

Postal Address
Molecular Genetics Laboratory
Biology Technical Support Centre
2 rue Angélique Ducoudray
Le Bocage University Hospital
21070 DIJON

 

Other axes

  • Area 1 : Treat
  • Area 2 : Innovate
  • Area 3 : Teach and Train
  • Area 4 : Humanise
  • Area 5 : Find

CHU Dijon - 14 rue Paul Gaffarel - BP 77908 - 21079 Dijon - France
Tél. : 03 80 29 53 13 - Fax : 03 80 29 32 66 - E-mail